Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Strongbridge Biopharma plc (SBBP)

2.93   -0.05 (-1.68%) 05-23 16:00
Open: 2.99 Pre. Close: 2.98
High: 3.03 Low: 2.82
Volume: 241,412 Market Cap: 159M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.036 - 3.053 3.053 - 3.072
Low: 2.774 - 2.792 2.792 - 2.812
Close: 2.895 - 2.927 2.927 - 2.963

Technical analysis

as of: 2019-05-23 4:28:09 PM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 4.86     One year: 5.83
Support: Support1: 2.82    Support2: 2.35
Resistance: Resistance1: 4.16    Resistance2: 4.99
Pivot: 3.17
Moving Average: MA(5): 2.97     MA(20): 3.48
MA(100): 4.59     MA(250): 4.99
MACD: MACD(12,26): -0.42     Signal(9): -0.42
Stochastic oscillator: %K(14,3): 12.52     %D(3): 9.41
RSI: RSI(14): 21.40
52-week: High: 7.65  Low: 2.82  Change(%): -59.9
Average Vol(K): 3-Month: 22755  10-Days: 23683

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
SBBP has closed above bottom band by 19.7%. Bollinger Bands are 16% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 02 May 2019 06:07:59 Z
Strongbridge Biopharma (SBBP) Q1 2019 Earnings Call Transcript

Wed, 01 May 2019 19:08:27 Z
Strongbridge Biopharma (SBBP) Reports Q1 Loss, Lags Revenue Estimates

Wed, 01 May 2019 17:15:10 Z
Strongbridge Biopharma plc (SBBP) Q1 2019 Earnings Call Transcript

Mon, 04 Mar 2019 16:14:06 Z
What's in the Cards for Aeterna (AEZS) This Earnings Season?

Tue, 26 Feb 2019 17:11:19 Z
Strongbridge Biopharma plc (SBBP) Q4 2018 Earnings Conference Call Transcript

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 54.17
Shares Float (M) 54.00
% Held by Insiders
% Held by Institutions 53.30
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS Est. Current Year -2.480
EPS Est. Next Year -1.180
EPS Est. Next Quarter -0.440
Forward EPS -1.231
Book Value (p.s.) 1.700
PEG Ratio
Profit Margin
Operating Margin -446.07
Return on Assets (ttm) 27.9
Return on Equity (ttm) 85.4
Qtrly Rev. Growth 12.2
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -84.86
Levered Free Cash Flow (M) -35.97

Stock Valuations

P/E -26391094417686528.00
P/E Growth Ratio -0.02
P/BV 1.72
P/S 417679200.00
P/CF -1.87

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.